FCA authorisation performance dips in Q2 2023


The Financial Conduct Authority has seen its authorisations performance in four out of five categories affecting brokers slip backwards in Q2 2023.

This contrasts with the first three months of the year, where the regulator saw improvements in four out of the five categories.

In the three months from the start of April to the end of June, the FCA processed 97.2% of applications on time for ‘approved person’ status submitted by an authorised firm under the Senior Manager and Certification Regime.

This was an improvement from 94.5% in Q1.

The watchdog has a statutory target of 100% being assessed within three months.

Though below the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

If you already have an account, please sign in here.


Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

FCA warns of Axa clone

The Financial Conduct Authority has warned of a clone claiming to be Axa Insurance UK and Axa Investment Managers UK.

Brokers pledge to stop sharing building commissions and cap fees

Five top 100 UK broking groups have pledged to end sharing building insurance commissions with landlords and to cap fees. However, many others have not signed up including Gallagher UK who has refused to back the pledge in its existing version over concerns about "possible unintended consequences".

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: